Amarin | AMRN - Capitale Sociale E Riserve

Prezzo Delle Azioni
13.87
Cambio Giornaliero
-0.42 -2.92%
Mensile
-0.55%
Annuale
28.93%
Q2 Previsione
13.88




Capitale Sociale E Riserve Cambiamento Data
AbbVie USD -3.27B 628M 2025-12
Alnylam Pharmaceuticals USD 1.08B 286.2M 2026-03
Amarin USD 449.41M 9.87M 2026-03
AstraZeneca USD 47.33B 1.33B 2026-03
BioCryst Pharmaceuticals USD -119.15M 268.74M 2025-12
DBV Technologies USD 52.85M 33.37M 2025-09
Esperion Therapeutics USD -301.96M 149.4M 2025-12
GlaxoSmithKline GBP 17.42B 1.05B 2026-03
Halozyme Therapeutics USD 48.81M 455.1M 2025-12
Heron Therapeutics USD 13.28M 1.6M 2025-12
Ionis Pharmaceuticals USD 491.41M 2.32M 2026-03
Nektar Therapeutics USD 89.83M 4.75M 2025-12
Neurocrine Biosciences USD 3.25B 249.5M 2025-12
Novartis USD 46.13B 1.38B 2025-12